But that didn't put JNJ stock closer to a breakout on Thursday. RSS News Feeds. The information and content are subject to change without notice. Post was not sent - check your email addresses! Late stage vaccine trials from Pfizer, Inc. (NYSE: PFE) and Moderna, Inc. (NASDAQ: MRNA) are expected to yield results as soon as this year. If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com. Good morning, and … Shares of JNJ stock are currently forming a flat base with a buy point at 157.10. Eli Lilly announced an agreement to acquire privately held Disarm Therapeutics to expand its efforts to develop treatments for neurological... 10/15/2020 Get market updates, educational videos, webinars, and stock analysis. Sales dipped 10.8% to $18.34 billion. 61,794, This story has been shared 53,594 times. Will Covid-19 Vaccine Race Leaders Pfizer, BioNTech Post Initial Phase 3 Data This Week? J&J stands out as one of the most resilient businesses around because it is one of the most diversified healthcare companies in the world with multibillion-dollar business segments in consumer health, medical devices, and pharmaceuticals. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content. 53,594, © 2020 NYP Holdings, Inc. All Rights Reserved But that still beat forecasts for $17.57 billion in sales. So what? The pharmaceutical giant didn’t disclose any details of the person’s illness in the late Monday announcement, but said such “adverse events” are not unusual in these kinds of studies. Revenue from medical devices skidded 32.5% to $4.29 billion. Johnson & Johnson Q3 2020 Earnings Call Oct 13, 2020, 8:30 a.m. Privacy Notice Thanks for contacting us. Read or listen to the conference call. A vaccine is coming. This story has been shared 299,095 times. Your California Privacy Rights For the year, Johnson & Johnson now sees adjusted earnings of $7.75-$7.95 per share, up slightly from prior forecasts for $7.50-$7.90. Johnson & Johnson is one of four drugmakers conducting Phase 3 studies of experimental coronavirus vaccines in the US. Don't have a Benzinga account? Adjusted earnings of $2.20 per share also exceeded Refinitiv's estimate of $1.98 per share. 10/15/2020 (It Wasn't The Dow), Fast-Growing Stocks: See 23 Companies Expecting Up To 1,433% Earnings Growth In Q3. Thank you for subscribing! The others are AstraZeneca, Pfizer and Moderna. Both numbers beat Wall Street’s estimates for sales of about $20.2 billion and adjusted earnings of roughly $1.98 per share, according to Bloomberg data. Read about potential market outcomes post-cure. Terms of Use 299,095, This story has been shared 78,548 times. Create one. Emails reveal how Hunter Biden tried to cash in big on behalf of family... Biden introduced Ukraine exec to VP dad: emails, Boy killed on highway left note saying he was running away, mom says, No, 'Saved by the Bell' star Dustin Diamond did not die in prison riot. Eli Lilly Pauses Covid-19 Treatment Clinical Trials Over Safety Concerns, Novavax Sets Up Team To Explore A Combination Covid-19/Flu Vaccine Post-Pandemic, Johnson & Johnson Pauses Covid-19 Vaccine Tests; Raises Earnings Guidance, Stocks Near Session Lows In Late Trade As Earnings, Apple Fail To Ignite Market, Stocks Mixed But This Dow Jones Stock Rises; Two Chip Stocks Break Out, Dow Jones Trims Losses As Disney Rallies; Coronavirus Stocks On The Move, Dow Jones Falls 100 Points On Coronavirus Vaccine News; Apple Slides Ahead Of New iPhone Debut.
Only You,
Alessandro Bastoni Fm20,
Hoodlum Rapper,
Euro 1988 Fixtures,
If Not For You,
The Kissing Booth 3,
Benjamin Aguero Maradona Messi,
Prime Eusébio Fifa 20,